Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy

Journal of Clinical Oncology

Volumn 11, Issue 6, 1993, Pages 1099-1107

  Pluda, James M ^a   Venzon, David J ^b   Tosato, Giovanna ^b   Lietzau, Jill ^b   Wyvill, Kathleen ^b   Nelson, David L ^b   Jaffe, Elaine S ^b   Karp, Judith E ^b   Broder, Samuel ^b   Yarchoan, Robert ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2',5' DIDEOXYADENOSINE; ACICLOVIR; ANTIGEN P24; ANTIVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

CD4-POSITIVE T-LYMPHOCYTES; DIDANOSINE; HIV INFECTIONS; HUMAN; INTERLEUKIN-6; LEUKOCYTE COUNT; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; RISK FACTORS; ZIDOVUDINE;

EID: 0027210354     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.6.1099     Document Type: Article

References (28)

1. Ziegler JL, Becksted JA, Volberding PA, et al: Non-Hodgkin's lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311:565-570, 1984
2. Levine AM, Meyer PR, Begandy MM, et al: Development of B-cell lymphoma in homosexual men: Clinical and immunological findings. Ann Intern Med 100:7-13, 1984
3. Levine AM, Gill PS, Meyer PR, et al: Retrovirus and malignant lymphoma in homosexual men. JAMA 254:1921-1925, 1985
4. Lowenthal DA, Straus DJ, Campbell SW, et al: AIDS-related lymphoid neoplasia: The Memorial Hospital experience. Cancer 61: 2325-2337, 1988
5. Knowles DM, Chamulak GA, Subar M, et al: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 108:744-753, 1988
6. Centers for Disease Control: Revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States. MMWR 34:373-375, 1985
7. Centers for Disease Control: HIV/AIDS Surveillance Report. Atlanta, GA, CDC, January 1992, pp 1-22
8. Pluda JM, Yarchoan R, Jaffe ES, et al: Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med 1 13:276-282, 1990
9. National Cancer Institute, Centers for Disease Control: Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy-United States. MMWR 40:591, 597-600, 1991
10. Yarchoan R, Klecker RW, Weinhold KJ, et al: Administration of 3′-azido-3′-deoxythymidine. an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet 1: 575-580, 1986
11. Yarchoan R, Broder S: Preliminary results on the use of di-deoxynucleosides in the therapy of AIDS, in Chanock RM, Lerner RA, Brown F, et al (eds): Vaccines 87: Modern Approaches to New Vaccines: Prevention of AIDS and Other Viral, Bacterial, and Parasitic Diseases. Cold Spring Harbor, NY. Cold Spring Harbor Laboratory, 1987. pp 214-224
12. Surbone A, Yarchoan R, McAtee N, et al: Treatment of acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3′-azido-2′,3′-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. Ann Intern Med 108:534-540, 1988
13. Yarchoan R, Thomas RV, Pluda J, et al: Long term treatment of severe human immunodeficiency virus (HIV) infection with an alternating regimen of two dideoxynucleosides. Clin Res 36:450A, 1988 (abstr)
14. Yarchoan R, Mitsuya H, Thomas RV, et al: In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine. Science 245:412-415, 1989
15. Yarchoan R, Pluda JM, Thomas RV, et al: Long-term toxicity/ activity profile of 2′,3′-dideoxyinosine in AIDS or AIDS-related complex. Lancet 336:526-529, 1990
16. Yarchoan R, Pluda JM, Perno C-F, et al: Anti-retroviral therapy of human immunodeficiency virus infection: Current strategies and challenges for the future. Blood 78:859-884, 1991
17. Jaffe ES, Cossman J: Immunodiagnosis of lymphoid and mononuclear phagocytic neoplasms, in Rose NR, Friedman H, Fahey JL (eds): Manual of Clinical Laboratory Immunology. Washington. DC, American Society for Microbiology. 1986, pp 779-790
18. Jaffe ES: Immune markers in the diagnosis of malignant lymphomas. J Virol Methods 21:265-274, 1988
19. Jaffe ES: The role of immunophenotypic markers in the classification of non-Hodgkin's lymphomas. Semin Oncol 17:11-19, 1990
20. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36:1S-15S, 1987 (suppl 1S)
21. Birx DL, Redfield RR, Tencer K, et al: Induction of IL-6 during human immunodeficiency virus infection. Blood 76:2303-2310, 1990
22. Rubin LA, Kurman CC, Fritz ME, et al: Soluble interlcukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135:3172-3177, 1985
23. Goudsmit J, de Wolf F, Paul DA, et al: Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 2:177-180, 1986
24. Reiss P, Lange JMA, Boucher CA, et al: Resumption of HIV antigen production during continuous zidovudine treatment. Lancet 1:421, 1988 (letter)
25. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
26. Rothman K: Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chron Dis 31:557-560, 1978
27. Yarchoan R, Venzon DJ, Pluda JM, et al: CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med 115:184-189, 1991
28. Cox DR, Hinckley DV (eds): Theoretical Statistics. London, England, Chapman & Hall, 1974, p 136